Evaluation of safe resection margins in tumours of parenchymatous organs
Authors:
M. Hermanová 1; R. Matěj 2; J. Dušková 3; E. Honsová 4; M. Tichý 1
Authors‘ workplace:
I. patologicko-anatomický ústav, FN u sv. Anny v Brně a Lékařská fakulta Masarykovy univerzity:
Prof. MUDr. M. Hermanová, Ph. D.
1; Oddělení patologie a molekulární medicíny, Thomayerova nemocnice: Doc. MUDr. R. Matěj, Ph. D.
2; Ústav patologie, Všeobecná fakultní nemocnice v Praze a 1. lékařská fakulta Univerzity Karlovy:
Doc. MUDr. P. Dundr, Ph. D.
3; Pracoviště klinické a transplantační patologie, Institut klinické a experimentální medicíny:
Doc. MUDr. E. Honsová, Ph. D.
4
Published in:
Rozhl. Chir., 2014, roč. 93, č. 2, s. 100-106.
Category:
Various Specialization
Práce je určena k postgraduálnímu vzdělávání lékařů.
Overview
The definition of a safe surgical margin in tumours of parenchymatous organs has been the subject of frequent debates and a number of studies. This topic is not generally unified for parenchymatous organs and has many organ specifics. Moreover, there are still controversies in the diagnostic criteria and the definitions of positive resection margins, in indications of perioperative examinations of resection margins, and in the prognostic significance of margin involvement in different parenchymatous organs. The consensus in terminology and standardization of histopathological examination procedures is also very desirable across the diagnostic areas.
Key words:
resection margins – tumours of parenchymatous organs
Sources
1. Verbeke CS. Resection margins in pancreatic cancer. Surg Clin North Am 2013;93:647–62.
2. Verbeke CS, Leitch D, Menon KV, et al. Redefining the R1 resection in pancreatic cancer. Br J Surg 2006;93:1232–7.
3. Menon KV, Gomez D, Smith AM, et al. Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP). HPB (Oxford) 2009;11:18–24.
4. Verbeke CS, Menon KV. Redefining resection margin status in pancreatic cancer. HPB (Oxford) 2009;11:282–9.
5. Verbeke CS, Knapp J, Gladhaug IP. Tumour growth is more dispersed in pancreatic head cancers than in rectal cancer: implications for resection margin assessment. Histopathology 2011; 59:1111–21.
6. Bandyopadhyay S, Basturk O, Coban I, et al. Isolated solitary ducts (naked ducts) in adipose tissue: a specific but underappreciated finding of pancreatic adenocarcinoma and one of the potential reasons of understaging and high recurrence rate. Am J Surg Pathol 2009;33:425–9.
7. Gill AJ, Johns AL, Eckstein R, et al. New South Wales Pancreatic Cancer Network (NSWPCN). Synoptic reporting improves histopathological assessment of pancreatic resection specimens. Pathology 2009;41:161–7.
8. Chang DK, Johns AL, Merrett ND, et al. Margin clearance and outcome in resected pancreatic cancer. J Clin Oncol 2009; 27:2855–62.
9. Hruban RH, Boffetta P, Hiraoka N, et al. Tumours of the pancreas. In: WHO classification of tumours of the digestive system. 4th Edn, Lyon, WHO Press 2010:279–338.
10. Hernandez J, Mullinax J, Clark W, et al. Survival after pancreaticoduodenectomy is not improved by extending resections to achieve negative margins. Ann Surg 2009;250:76–80.
11. Nelson DW, Blanchard TH, Causey MW, et al. Examining the accuracy and clinical usefulness of intraoperative frozen section analysis in the management of pancreatic lesions. Am J Surg 2013;205:613–7.
12. Dillhoff M, Yates R, Wall K, et al. Intraoperative assessment of pancreatic neck margin at the time of pancreaticoduodenectomy increases likelihood of margin-negative resection in patients with pancreatic cancer. J Gastrointest Surg 2009;13:825–30.
13. Maygarden SJ, Detterbeck FC, Funkhouser WK. Bronchial margins in lung cancer resection specimens: utility of frozen section and gross evaluation. Mod Pathol 2004;17:1080–6.
14. Owen RM, Force SD, Gal AA, et al. Routine intraoperative frozen section analysis of bronchial margins is of limited utility in lung cancer resection. Ann Thorac Surg 2013;95:1859-65; discussion 1865–6.
15. Tomaszek SC, Wigle DA. Surgical management of lung cancer. Semin Respir Crit Care Med 2011;32:69–77.
16. Tomaszek SC, Kim Y, Cassivi SD, et al. Bronchial resection margin length and clinical outcome in non-small cell lung cancer. Eur J Cardiothorac Surg 2011;40:1151–6.
17. ValliŹres E, Van Houtte P, Travis WD, et al. International Association for the Study of Lung Cancer (IASLC) International Staging Committee. Carcinoma in situ at the bronchial resection margin: a review. J Thorac Oncol 2011;6:1617–23.
18. Hofmann HS, Taege C, Lautenschläger C, et al. Microscopic (R1) and macroscopic (R2) residual disease in patients with resected non-small cell lung cancer. Eur J Cardiothorac Surg 2002;21: 606–10.
19. Kara M, Sak SD, Orhan D, Yavuzer S. Changing patterns of lung cancer; (3/4 in.) 1.9 cm; still a safe length for bronchial resection margin? Lung Cancer 2000;30:161–8.
20. Van Poppel H. Efficacy and safety of nephron-sparing surgery. Int J Urol 2010;17:314–26.
21. Porpiglia F, Fiori C, Terrone C, et al. Assessment of surgical margins in renal cell carcinoma after nephron sparing: a comparative study: laparoscopy vs open surgery. J Urol 2005;173:1098–101.
22. Sivarajan G, Huang WC. Current practice patterns in the surgical management of renal cancer in the United States. Urol Clin North Am 2012;39:149–60.
23. Marszalek M, Carini M, Chlosta P, et al. Positive surgical margins after nephron-sparing surgery. Eur Urol 2012;61:757–63.
24. Borghesi M, Brunocilla E, Schiavina R, Martorana G. Positive surgical margins after nephron-sparing surgery for renal cell carcinoma: incidence, clinical impact, and management. Clin Genitourin Cancer 2013;11:5–9.
25. Sutherland SE, Resnick MI, Maclennan GT, Goldman HB. Does the size of the surgical margin in partial nephrectomy for renal cell cancer really matter? J Urol 2002;167:61–4.
26. Kubinski DJ, Clark PE, Assimos DG, Hall MC. Utility of frozen section analysis of resection margins during partial nephrectomy. Urology 2004;64:31–4.
27. Venigalla S, Wu G, Miyamoto H: The Impact of Frozen Section Analysis During Partial Nephrectomy on Surgical Margin Status and Tumor Recurrence: A Clinicopathologic Study of 433 Cases. Clin Genitourin Cancer 2013 Jul 16. pii: S1558– 7673(13)00134?1. doi: 10.1016/j.clgc.2013.05.003. [Epub ahead of print]
28. Raz O , Mendlovic S, Shilo Y, et al. Positive surgical margins with renal cell carcinoma have a limited influence on long-term oncological outcomes of nephron sparing surgery. Urology 2010;75:277–80.
29. Sterious SN, Simhan J, Smaldone MC, et al. Is there a benefit to frozen section analysis at the time of partial nephrectomy? Can J Urol 2013;20:6778–84.
30. Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 2011;149:713–24.
31. Ferrero A, Viganė L, Polastri R, et al. Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study. World J Surg 2007;31(8):1643–51.
32. Adams RB, Aloia TA, Loyer E, et al. Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB Oxford 2013;15:91–103.
33. Jarnagin W, Chapman WC, Curley S, et al. Surgical treatment of hepatocellular carcinoma: expert consensus statement. HPB Oxford 2010;12:302–10.
34. Sadamori H, Yagi T, Shinoura S, et al. Risk factors for major morbidity after liver resection for hepatocellular carcinoma. Br J Surg 2013;100:122–9.
35. Nobili C, Marzano E, Oussoultzoglou E, et al. Multivariate analysis of risk factors for pulmonary complications after hepatic resection. Ann Surg 2012;255:540–50.
36. Hyder O, Pulitano C, Firoozmand A, et al. A risk model to predict 90-day mortality among patients undergoing hepatic resection. J Am Coll Surg 2013;216:1049–56.
Labels
Surgery Orthopaedics Trauma surgeryArticle was published in
Perspectives in Surgery
2014 Issue 2
Most read in this issue
- Evaluation of safe resection margins in tumours of parenchymatous organs
- Evaluation of safe resection margins in rectal carcinoma
- Evaluation of safe margins in pathology examination in breast oncosurgery
- Clostridium colitis at a surgical department